Skip to main content
Premium Trial:

Request an Annual Quote

Caprotec Hauls in $6.6M in Venture Funding

NEW YORK (GenomeWeb News) – Caprotec Bioanalytics said today that it has raised €4.5 million ($6.6 million) through investments from VC Fonds Berlin, the ERP Startfonds, and from other private investors.
The company plans to use the money to develop and sell its CCMS proteomics analysis technology, which uses tri-functional molecules called capture compounds and complements 2D gel electrophoresis and affinity chromatography. The capture compounds serve as chemical probes by detecting proteins directly in solutions, the company said.
The startup plans to initiate operations by moving into new facilities in Berlin-Adlershof and staffing up. Caprotec also will begin developing kits for proteomics R&D and for drug and biomarker development.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.